DGX logo

QUEST DIAGNOSTICS INC

DGXNYSE
πŸ† #394 by market capEarnings Oct 20US Equity
$237.50β–Ό $0.12 (βˆ’0.05%)
πŸŒ™ After hours$237.50β–² 0.00%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 0.1%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$26.21B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+9.9%
Slowing
πŸ“ŠGross Margin
33.2%
Moderate
πŸ’΅FCF Margin
11.7%
Healthy
βš–οΈP/S Ratio
2.3x
Cheap
Otter Score
48
Weak
No chart data available for DGX.

Trading Snapshot

Day Range
$234.24 – $241.41
52-Week Range
$171.18 – $240.13
Volume
$4.54B
Avg Volume
$3.22B
Shares Outstanding
110.4M
Next Earnings
Sep 14, 2026

Fundamentals Snapshot

Annual Revenue
$11.04B
Last Q Revenue
$3.04B
P/E Ratio
24.6
P/S Ratio
2.3x
EPS (TTM)
$9.44
Dividend Yield
1.39%

Why Investors Own DGX

  • βœ“High-growth profile β€” revenue up +37.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 40% gross margin and 12% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$11.04Bβ–² +41.6% YoY
Gross Margin (TTM)
39.8%β–Ό βˆ’0.3% YoY
Operating Income (TTM)
$2.06Bβ–² +41.6% YoY
Free Cash Flow (TTM)
$1.32Bβ–² +41.6% YoY

About QUEST DIAGNOSTICS INC

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
48/100

Analyst Price Target

β“˜
Average Target
$248.30
β–² +4.5% Upside
High Target$306.40
Low Target$233.02
Based on 12 analysts

Latest News & Updates